LIfT BioSciences
PrivateLast Round
Grant
Jul 29, 2025
Total Funding Raised
$1.26M
Company Overview
LIfT BioSciences is a biotechnology company developing a first-in-class, allogeneic neutrophil-based cell therapy platform to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LIfT BioSciences Comparables
Compare LIfT BioSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hybrid Bio | 83% | |
| Zelluna ASA | 78% | |
| HebeCell | 77% |
LIfT BioSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 29, 2025 | ||||
| Series A | Sep 24, 2024 | ||||
| Grant | May 16, 2024 | ||||
| Seed | Dec 19, 2022 | ||||
| VC Round | Jan 21, 2022 |
LIfT BioSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kizoo Technology Capital | VC Round |
| Starbloom Capital | Series A, Seed, VC Round |
| Innovate UK | Grant |
| Downing Ventures | VC Round |
| LifeSpan Vision Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2025
$14M raised in grant funding.
- Sep 24, 2024
$13.4M round with participation from LifeSpan Vision Ventures and Starbloom Capital.
LIfT BioSciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LIfT BioSciences's valuation, stock price, and market status.
Is LIfT BioSciences a public or private company?
LIfT BioSciences is a private company.
What is the current stock price of LIfT BioSciences?
LIfT BioSciences is a private company, so its shares have no public market price. Caplight tracks LIfT BioSciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LIfT BioSciences worth (valuation)?
Valuation information for LIfT BioSciences is not publicly available.
Can I buy LIfT BioSciences stock?
LIfT BioSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LIfT BioSciences's last funding round?
LIfT BioSciences's most recent funding round was Grant on July 29, 2025.
Who are the main investors in LIfT BioSciences?
Key investors in LIfT BioSciences include Starbloom Capital.
Will LIfT BioSciences IPO soon?
No public IPO plans have been announced for LIfT BioSciences.
How can I track LIfT BioSciences secondary market activity?
Caplight tracks bids, offers, and trades in LIfT BioSciences's shares on secondary markets.